Clinical Trials | August 18, 2022
Sanofi updates on amcenestrant clinical development program
The decision is based on the outcome of a prespecified interim analysis of the Phase 3 AMEERA-5 trial
The decision is based on the outcome of a prespecified interim analysis of the Phase 3 AMEERA-5 trial
The study concluded that elevated levels of two proteins help predict how a person will recover from a traumatic brain injury (TBI), providing important information to determine appropriate care
Collaboration supports multiple discovery efforts, including vaccines
Collaboration focuses on developing and implementing real-world research to drive patient access to cancer medicines
All claims made by Seagen regarding Daiichi Sankyo antibody drug conjugates are denied
Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of age
Use of IVUS recommended in all phases of lower extremity arterial and venous revascularization procedures to guide clinical decisions
AstraZeneca has acquired all outstanding equity of TeneoTwo in exchange for an upfront payment of $100m.
New deal strengthens Congenica’s presence in India
MeitY will provide technical support for digitalisation of the Ayush Sector under the Ayush Grid project for a period of three years
Subscribe To Our Newsletter & Stay Updated
